You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Retinal Neoplasms

Showing 1 - 25 of 3,943
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Retinoblastoma, Retinal Tumor Trial in Memphis (procedure, drug, radiation, other)

Active, not recruiting
Has Results
  • Retinoblastoma
  • Retinal Neoplasm
  • Enucleation
  • +9 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jan 10, 2022

Cardiovascular Toxicity: Comprehensive Myocardial and Vascular

Recruiting
  • Cardiovascular Diseases
  • +7 more
  • Cardiovascular magnetic resonance with stress perfusion
  • +4 more
  • London, United Kingdom
    St Bartholomews Hospital
Sep 15, 2023

Exudative Retinal Detachment and Uveal Melanoma Trial in Boston (Dexamethasone intravitreal implant)

Recruiting
  • Exudative Retinal Detachment and Uveal Melanoma
  • Dexamethasone intravitreal implant
  • Boston, Massachusetts
    i. Ocular Melanoma Center, Massachusetts Eye and Ear
Jul 23, 2021

Pancreatic Cancer and Purtscher-like Retinopathy

Completed
  • Purtscher Retinopathy
  • Pancreatic Cancer
  • Catania, Italy
    Eva Intagliata
Apr 23, 2022

Colorectal Cancer Trial in Dijon (OCT- Angiographie)

Recruiting
  • Colorectal Cancer
  • OCT- Angiographie
  • Dijon, France
  • +1 more
Jul 2, 2021

Retinoblastoma, Retinal Tumors Trial in Chicago (Carboplatin, VP-16, Local Surgery)

Completed
  • Retinoblastoma
  • Retinal Neoplasms
  • Chicago, Illinois
    Children's Memorial Hospital
Aug 3, 2020

Retinal Vascular Changes After Endoscopic Endonasal Pituitary

Completed
  • Pituitary Adenoma
  • Endoscopic endonasal pituitary surgery
  • Naples, Italy
    University of Naples "Federico II"
Feb 1, 2021

Retinoblastoma, Children, Retinal Tumor Trial in Paris (drug, device, radiation)

Recruiting
  • Retinoblastoma
  • +2 more
  • VP16, carboplatin
  • +7 more
  • Paris, France
    Institut Curie
Aug 6, 2020

Early Retinal Vascular Modifications After Endoscopic Endonasal

Completed
  • Pituitary Adenoma
  • Endoscopic Endonasal Pituitary Surgery
  • Naples, Italy
    University of Naples "Federico II"
Jun 11, 2020

Branch Retinal Vein Occlusion Trial in Worldwide (Brolucizumab 6 mg, Aflibercept 2 mg, Sham injection)

Terminated
Has Results
  • Branch Retinal Vein Occlusion
  • Brolucizumab 6 mg
  • +2 more
  • Phoenix, Arizona
  • +101 more
Jan 27, 2023

Retinal Vein Occlusion Trial in Bethesda, Bristol (Minocycline, Placebo, Bevacizumab)

Completed
Has Results
  • Retinal Vein Occlusion
  • Bethesda, Maryland
  • +1 more
Dec 27, 2021

Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

Recruiting
  • Rare Disorders
  • +309 more
    • Sioux Falls, South Dakota
    • +1 more
    Jun 20, 2022

    Diabetic Macular Edema, Retina Vein Occlusion Trial in United States (GB-102)

    Completed
    Has Results
    • Diabetic Macular Edema
    • Retina Vein Occlusion
    • Phoenix, Arizona
    • +5 more
    Nov 18, 2021

    The Myeloid Neoplasms Biology and Outcome Project

    Recruiting
    • Myeloid Neoplasm
      • Heidelberg, Baden-Württemberg, Germany
        UHHeidelberg
      Nov 21, 2022

      True Exocrine Epithelial Pancreatic Cystic Neoplasms Based on

      Completed
      • Pancreas Cancer
      • surgical resection
      • (no location specified)
      Apr 22, 2022

      Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01)

      Recruiting
      • Digestive System Neoplasms
      • iNeo-Vac-R01
      • Hangzhou, Zhejiang, China
        Department of General Surgery, Institute of Minimally Invasive S
      Sep 8, 2023

      Biliary Tract Tumors Trial (Total Neoadjuvant Treatment)

      Not yet recruiting
      • Biliary Tract Neoplasms
      • Total Neoadjuvant Treatment
      • (no location specified)
      Sep 7, 2023

      Orthopedic Oncology Surgery: Navigation, Intraoperative Imaging

      Recruiting
      • Neoplasms
      • Muscle Neoplasm
      • evaluate the quality of surgical margins achievable with the use of navigated Intraoperative CT
      • Rome, Italy
        "Regina Elena" National Cancer Institute
      Jun 15, 2023

      MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)

      Recruiting
      • MDS/MPN
      • Azacitidine (AZA) with Ruxolitinib
      • Nanjing, Jiangsu, China
        The First Affiliated Hospital of Nanjing Medical University
      Apr 17, 2023

      Endoscopic Mucosal Resection With Circumferential Incision Trial in Moscow (Endoscopic mucosal resection with circumferential

      Active, not recruiting
      • Endoscopic Mucosal Resection With Circumferential Incision
      • Endoscopic mucosal resection with circumferential incision
      • Endoscopic submucosal dissection
      • Moscow, Russian Federation
        Elmira
      Jan 10, 2023

      Epidemiological and Clinical-pathological Factors of

      Completed
      • Myeloproliferative Neoplasm
      • +4 more
        • Guayaquil, Guayas, Ecuador
          Sociedad de Lucha Contra el Cáncer
        Apr 25, 2023

        Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01 in combination with standard adjuvant therapy)

        Recruiting
        • Digestive System Neoplasms
        • iNeo-Vac-R01 in combination with standard adjuvant therapy
        • Hangzhou, Zhejiang, China
          Department of General Surgery, Institute of Minimally Invasive S
        Sep 8, 2023

        After Endoscopic Endonasal Pituitary Surgery

        Completed
        • Pituitary Adenoma
        • Endoscopic Endonasal Pituitary Surgery
        • Naples, Italy
          University of Naples "Federico II"
        May 3, 2021

        Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01)

        Recruiting
        • Digestive System Neoplasms
        • iNeo-Vac-R01
        • Hangzhou, Zhejiang, China
          Department of General Surgery, Institute of Minimally Invasive S
        Sep 8, 2023

        CD70-positive Advanced Urologic Tumors Trial in Shanghai (Anti-CD70 CAR-T cells)

        Recruiting
        • CD70-positive Advanced Urologic Neoplasms
        • Anti-CD70 CAR-T cells
        • Shanghai, Shanghai, China
          Changhai Hospital
        Aug 11, 2023